EPA and DHA omega-3s from food and supplements may reduce the risk of coronary heart disease (CHD), according to results of a new meta-analysis.
Data from 18 randomized clinical trials (RCTs) indicated that EPA and DHA were associated with a non-statistically significant 6% risk reduction in CHD among all populations, while the risk reduction increased to a statistically significant 18% when data from 16 prospective cohort studies was assessed.
A trial reported in 2016 indicates that supplementation with omega 3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can help improve major depression.
The study shows that both high levels of EPA+DHA at baseline and supplementation with these two omega 3 fatty acids result in favorable post-treatment outcomes in major depression patients.
New research suggests that eating a Mediterranean diet may prolong the lives of heart patients.
“Adherence to the Mediterranean diet reduces the risk of overall mortality, not only in the general population — which is already known, but in patients who already suffered a heart attack,” said study researcher Dr. Giovanni de Gaetano. He is head of the department of epidemiology and prevention at the I.R.C.C.S. Neuromed Institute in Pozzilli, Italy. Continue reading “Mediterranean diet better for the heart than taking statins, major study suggests”